Abstract
A common feature of sarcoidosis and atherosclerosis is a chronic systemic inflammatory reaction. Our hypothesis was that sarcoidosis may negatively influence the vessel status. We addressed the issue by examining preatherosclerotic vascular alternations using an ultrasound-based speckle-tracking method in 72 sarcoidosis patients and 15 matched controls. To find potential factors which may have a deleterious influence on arterial performance, different subgroups of sarcoidosis, such as sarcoidosis with or without cortisone therapy, pulmonary sarcoidosis in early and advanced stages, pulmonary sarcoidosis alone or combined with extrapulmonary sarcoidosis, and sarcoidosis with or without elevated blood levels of angiotensin converting enzyme (ACE)/soluble interleukin 2 receptor (sIL-2R) were investigated. We found in the general collective of sarcoidosis patients that circumferential strain (2.68 ± 0.19%), circumferential strain rate (0.21 ± 0.01 1/s), and radial displacement (0.10 ± 0.01 mm) were significantly decreased compared to controls (3.77 ± 0.35%, 0.28 ± 0.02 1/s, and 0.14 ± 0.02 mm, respectively). Vascular strains were more impaired in patients with cortisone therapy, pulmonary sarcoidosis in stages III-IV, and in pulmonary sarcoidosis accompanied by extrapulmonary involvement. The level of ACE/sIL-2R had no relevant influence on the angiological parameters. In conclusion, sarcoidosis is associated with increased vascular stiffness. Cortisone therapy and advanced stages of pulmonary sarcoidosis with extrapulmonary manifestations may account for the impaired vascular function in this patient collective.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Au K, Singh MK, Bodukam V, Bae S, Maranian P, Ogawa R, Spiegel B, McMahon M, Hahn B, Khanna D (2011) Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum 63:2078–2090
de Leeuw K, Sanders JS, Stegeman C, Smit A, Kallenberg CG, Bijl M (2005) Accelerated atherosclerosis in patients with Wegener’s granulomatosis. Ann Rheum Dis 64:753–759
Frerix M, Stegbauer J, Kreuter A, Weiner SM (2014) Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events. Arthritis Res Ther 16:R54
Gordon D, Kobernick SD, McMillan GC, Duff GL (1954) The effect of cortisone on the serum lipids and on the development of experimental cholesterol atherosclerosis in the rabbit. J Exp Med 99:371–386
Hafström I, Rohani M, Deneberg S, Wörnert M, Jogestrand T, Frostegård J (2007) Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study. J Rheumatol 34:1810–1816
Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS, Noonan H, Nunes CN, Olson SH, Pikounis B, Ren N, Robertson N, Schaeffer JM, Shah K, Springer MS, Strack AM, Strowski M, Wu K, Wu T, Xiao J, Zhang BB, Wright SD, Thieringer R (2005) 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med 202:517–527
Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, Donald AE, Palacios M, Griffin GE, Deanfield JE, MacAllister RJ, Vallance P (2000) Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 102:994–999
Ivanišević J, Kotur-Stevuljević J, Stefanović A, Jelić-Ivanović Z, Spasić S, Videnović-Ivanov J, Vučinić-Mihailović V, Ilić J (2012) Dyslipidemia and oxidative stress in sarcoidosis patients. Clin Biochem 45:677–682
Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224–1234
Nienhuis HL, de Leeuw K, Smit AJ, Bijzet J, Stegeman CA, Kallenberg CG, Bijl M (2007) Enhanced endothelium-dependent microvascular responses in patients with Wegener’s granulomatosis. J Rheumatol 34:1875–1881
Nunes H, Humbert M, Capron F, Brauner M, Sitbon O, Battesti JP, Simonneau G, Valeyre D (2006) Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 61:68–74
Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Hanly JG, Petri M, Steinsson K, Dooley MA, Manzi S, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Bruce IN (2013) Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis 72:1308–1314
Ross R (1999) Atherosclerosis is an inflammatory disease. Review. Am Heart J 138:S419–S420
Siasos G, Paraskevopoulos T, Gialafos E, Rapti A, Oikonomou E, Zaromitidou M, Mourouzis K, Siasou G, Gouliopoulos N, Tsalamandris S, Vlasis K, Stefanadis C, Papavassiliou AG, Tousoulis D (2015) Vascular function and ocular involvement in sarcoidosis. Microvasc Res 100:54–58
Souza AW, de Leeuw K, van Timmeren MM, Limburg PC, Stegeman CA, Bijl M, Westra J, Kallenberg CG (2014) Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis. PLoS One 9:e96067
Tuleta I, Pingel S, Biener L, Pizarro C, Hammerstingl C, Öztürk C, Schahab N, Grohé C, Nickenig G, Schaefer C, Skowasch D (2016) Atherosclerotic vessel changes in Sarcoidosis. Adv Exp Med Biol 910:23–30
Tyrrell PN, Beyene J, Feldman BM, McCrindle BW, Silverman ED, Bradley TJ (2010) Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 30:1014–1026
Vettori S, Maresca L, Cuomo G, Abbadessa S, Leonardo G, Valentini G (2010) Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment. Scand J Rheumatol 39:485–489
Yildiz M (2010) Arterial distensibility in chronic inflammatory rheumatic disorders. Open Cardiovasc Med J 4:83–88
Zhang L, Yin JK, Duan YY, Liu X, Xu L, Wang J, Yang YL, Yuan LJ, Cao TS (2014) Evaluation of carotid artery elasticity changes in patients with type 2 diabetes. Cardiovasc Diabetol 13:39
Acknowledgments
We gratefully acknowledge Sonotechnik Austria for providing us with the AngE Pro8®. We would like to thank all patients who participated in the study and the Sarkoidose-Netzwerk for its support.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tuleta, I. et al. (2017). Impaired Vascular Function in Sarcoidosis Patients. In: Pokorski, M. (eds) Respiratory System Diseases. Advances in Experimental Medicine and Biology(), vol 980. Springer, Cham. https://doi.org/10.1007/5584_2016_203
Download citation
DOI: https://doi.org/10.1007/5584_2016_203
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59497-2
Online ISBN: 978-3-319-59498-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)